CVS HEALTH CORPORATION vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| CVS | NVDA | |
|---|---|---|
| Market Cap | $126.47 billion | $5.31 trillion |
| Revenue (TTM) | — | $253.49 billion |
| Net Income (TTM) | — | $159.61 billion |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| CVS | NVDA | |
|---|---|---|
| P/E Ratio | — | 33.57 |
| Price / Book | 1.63 | 27.16 |
| Price / Sales | — | 20.95 |
CVS leads on 1 of 1 valuation factors.
Profitability
| CVS | NVDA | |
|---|---|---|
| Net Margin | — | 62.97% |
| Return on Equity | — | 81.65% |
CVS and NVDA split the profitability factors evenly.
Dividend
| CVS | NVDA | |
|---|---|---|
| Dividend Yield | 2.68% | — |
CVS and NVDA split the dividend factors evenly.
Risk & Sentiment
| CVS | NVDA | |
|---|---|---|
| Short Interest | 2.58% | 0.07% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CVS overview, CVS financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.